Related Experiment Video
Updated: May 8, 2026

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery
Published on: September 26, 2025
Room temperature stability of injectable succinylcholine dichloride.
Julie J Roy1, Daniel Boismenu, Orval A Mamer
1S.M.B.D.-Jewish General Hospital, Montreal, Quebec, Canada.
Commercially available intravenous succinylcholine dichloride (Quelicin) exhibits good room temperature stability. This muscle relaxant can be safely stored for up to six months at room temperature.
Area of Science:
- Pharmaceutical Science
- Analytical Chemistry
Background:
- Succinylcholine dichloride is a critical neuromuscular blocking agent used in anesthesia.
- Understanding the stability of intravenous formulations is essential for clinical practice and drug management.
Purpose of the Study:
- To assess the room temperature stability of commercial intravenous succinylcholine dichloride (Quelicin) over several months.
- To provide data supporting safe storage conditions for this medication.
Main Methods:
- Utilized a validated electro-spray tandem mass spectrometry method for succinylcholine dichloride quantification.
- Employed a stable isotope dilution assay with hexadeuterosuccinylcholine diiodide as the internal standard.
- Established calibration curves based on product ion intensity ratios.
Main Results:
- The analytical method demonstrated specificity, sensitivity, and reproducibility.
- Succinylcholine dichloride concentration declined linearly over the study period.
- After 1, 3, and 6 months at room temperature, vial contents retained approximately 98%, 95%, and 90% of initial concentration, respectively.
Conclusions:
- Succinylcholine dichloride (Quelicin) demonstrates acceptable stability at room temperature for up to six months.
- The findings support the safe storage of succinylcholine dichloride vials at room temperature under normal daylight conditions for this duration.
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Drug Product Stability
Skeletal Muscle Relaxants: Therapeutic Uses
